Neurotech International Limited

ASX:NTI.AX

0.053 (AUD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q32016 Q22016 Q1
Revenue -0.0330.0020.0030.0030.4080.0480.1750.0310.0410.0360.0110.184-0.0220.0520.0480.040.12800.0850.042
Cost of Revenue 2.2320.9512.2112.0211.1510.3550.2530.1920.3250.2980.7050.9550.060.0270.1350.1230.04500.0070.003
Gross Profit -2.265-0.949-2.208-2.018-0.742-0.308-0.077-0.161-0.284-0.262-0.695-0.771-0.0820.025-0.087-0.0830.08300.0780.039
Gross Profit Ratio 68.132-629.858-743.115-675.265-1.818-6.446-0.441-5.244-6.938-7.203-64.895-4.1923.6710.48-1.81-2.0580.64600.9170.917
Reseach & Development Expenses 3.012.2374.2452.2071.3941.1842.9030.281000.0430.0630.2360.0540.2090.0340.028000
General & Administrative Expenses 0.620.5090.4430.5060.2790.4310.4110.2590.3210.3390.6610.5150.3440.7110.2730.9480.36400.1420.071
Selling & Marketing Expenses 0.0050.0060.0060.0050.0010.0140.0070.0050.0020.0170.0340.1690.0820.0350.0460.0680.03700.0130.006
SG&A 1.8130.7450.0510.5020.5360.4690.8943.1790.2840.4390.7410.7431.2371.3631.1771.7091.71900.4580.229
Other Expenses -0.00800000.0150.0510000000000000
Operating Expenses 4.8242.9834.2962.713.1171.6393.7463.460.2840.4390.7410.8071.9951.951.8491.9962.2100.6770.338
Operating Income -7.089-3.932-4.294-4.727-1.558-1.947-3.824-3.622-0.569-0.701-1.436-1.577-1.958-1.791-1.799-2.092-1.8110-0.588-0.294
Operating Income Ratio 213.23-2,609.025-1,445.459-1,582.125-3.816-40.782-21.801-117.76-13.874-19.275-134.142-8.57987.506-34.161-37.424-52.011-14.1380-6.956-6.955
Total Other Income Expenses Net 2.7480.0280.04100.0090.1340.016-0.001-0.382-0.062-1.585-0.204-0.096-0.145-0.126-0.014-0.3710-0.023-0.012
Income Before Tax -4.34-3.904-4.254-4.727-1.55-1.813-3.808-3.623-0.95-0.763-3.021-1.781-2.055-1.936-1.925-2.107-2.1810-0.611-0.306
Income Before Tax Ratio 130.56-2,590.671-1,431.674-1,581.983-3.794-37.976-21.711-117.798-23.185-20.978-282.225-9.68991.81-36.922-40.04-52.366-17.0320-7.232-7.232
Income Tax Expense 2.59-3.1750-1.1890-1.803-3.827-3.622-0-00.335-000000000
Net Income -4.34-0.729-4.254-3.538-1.55-1.813-3.808-3.623-0.95-0.763-3.021-1.781-2.055-1.936-1.925-2.107-2.1810-0.611-0.306
Net Income Ratio 130.56-483.591-1,431.674-1,184.215-3.794-37.976-21.711-117.798-23.185-20.978-282.225-9.68991.81-36.922-40.04-52.366-17.0320-7.232-7.232
EPS -0.005-0.001-0.005-0.005-0.002-0.003-0.006-0.007-0.006-0.006-0.024-0.014-0.019-0.021-0.022-0.034-0.060-0.019-0.009
EPS Diluted -0.005-0.001-0.005-0.005-0.002-0.003-0.006-0.007-0.006-0.006-0.024-0.014-0.019-0.021-0.022-0.034-0.060-0.019-0.009
EBITDA -4.498-3.932-4.293-4.727-3.361-1.947-3.824-3.622-0.528-0.661-1.407-1.27-2.076-1.548-1.798-1.968-1.7530-0.523-0.262
EBITDA Ratio 135.309-2,608.832-1,445.069-1,581.928-8.23-40.782-21.801-117.76-12.885-18.161-131.403-6.90892.747-29.534-37.401-48.912-13.6870-6.193-6.193